205 related articles for article (PubMed ID: 34958511)
1. Molecular testing for melanocytic tumors: a practical update.
Andea AA
Histopathology; 2022 Jan; 80(1):150-165. PubMed ID: 34958511
[TBL] [Abstract][Full Text] [Related]
2. Molecular testing in melanoma for the surgical pathologist.
Andea AA
Pathology; 2023 Mar; 55(2):245-257. PubMed ID: 36653236
[TBL] [Abstract][Full Text] [Related]
3. Molecular diagnostics for ambiguous melanocytic tumors.
Shahbain H; Cooper C; Gerami P
Semin Cutan Med Surg; 2012 Dec; 31(4):274-8. PubMed ID: 23174498
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements.
Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST
Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744
[TBL] [Abstract][Full Text] [Related]
5. Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions.
Zembowicz A; Yang SE; Kafanas A; Lyle SR
Arch Pathol Lab Med; 2012 Dec; 136(12):1571-9. PubMed ID: 22480223
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Immunohistochemistry for PRAME With Cytogenetic Test Results in the Evaluation of Challenging Melanocytic Tumors.
Lezcano C; Jungbluth AA; Busam KJ
Am J Surg Pathol; 2020 Jul; 44(7):893-900. PubMed ID: 32317605
[TBL] [Abstract][Full Text] [Related]
7. Mitotically Active Nevus and Nevoid Melanoma: A Clinicopathological and Molecular Study.
Mesbah Ardakani N; Singh S; Thomas C; Van Vliet C; Harvey NT; Calonje JE; Wood BA
Am J Dermatopathol; 2021 Mar; 43(3):182-190. PubMed ID: 32649342
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence in situ hybridization for ambiguous melanocytic tumors.
Gammon B; Gerami P
Histol Histopathol; 2012 Dec; 27(12):1539-42. PubMed ID: 23059884
[TBL] [Abstract][Full Text] [Related]
9. Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors.
Al-Rohil RN; Curry JL; Torres-Cabala CA; Nagarajan P; Ivan D; Aung PP; Lyons GF; Bassett RL; Prieto VG; Tetzlaff MT
Hum Pathol; 2016 Jul; 53():73-81. PubMed ID: 27004944
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases.
Vergier B; Prochazkova-Carlotti M; de la Fouchardière A; Cerroni L; Massi D; De Giorgi V; Bailly C; Wesselmann U; Karlseladze A; Avril MF; Jouary T; Merlio JP
Mod Pathol; 2011 May; 24(5):613-23. PubMed ID: 21151100
[TBL] [Abstract][Full Text] [Related]
11. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence in-situ hybridization analysis for melanoma diagnosis.
Senetta R; Paglierani M; Massi D
Histopathology; 2012 Apr; 60(5):706-14. PubMed ID: 22007736
[TBL] [Abstract][Full Text] [Related]
13. Molecular testing to differentiate melanoma from benign nevi: The gold standard limitation.
Bitterman A
J Am Acad Dermatol; 2016 Oct; 75(4):849-850. PubMed ID: 27646748
[No Abstract] [Full Text] [Related]
14. Use of New Techniques in Addition to IHC Applied to the Diagnosis of Melanocytic Lesions, With Emphasis on CGH, FISH, and Mass Spectrometry.
Nagarajan P; Tetzlaff MT; Curry JL; Prieto VG
Actas Dermosifiliogr; 2017; 108(1):17-30. PubMed ID: 27344067
[TBL] [Abstract][Full Text] [Related]
15. [Molecular diagnosis of melanocytic tumors].
Bauer J
Hautarzt; 2016 Jan; 67(1):59-63. PubMed ID: 26589514
[TBL] [Abstract][Full Text] [Related]
16. FISH as an effective diagnostic tool for the management of challenging melanocytic lesions.
Moore MW; Gasparini R
Diagn Pathol; 2011 Aug; 6():76. PubMed ID: 21834951
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of melanoma and benign nevi by fluorescence in-situ hybridization.
Hossain D; Qian J; Adupe J; Drewnowska K; Bostwick DG
Melanoma Res; 2011 Oct; 21(5):426-30. PubMed ID: 21900793
[TBL] [Abstract][Full Text] [Related]
18. Discordance in the histopathologic diagnosis of difficult melanocytic neoplasms in the clinical setting.
Lodha S; Saggar S; Celebi JT; Silvers DN
J Cutan Pathol; 2008 Apr; 35(4):349-52. PubMed ID: 18333894
[TBL] [Abstract][Full Text] [Related]
19. Molecular testing of borderline cutaneous melanocytic lesions: SNP array is more sensitive and specific than FISH.
Carter MD; Durham AB; Miedema JR; Harms PW; Chan MP; Patel RM; Lowe L; Fullen DR; Hristov AC; Wang M; Andea AA
Hum Pathol; 2019 Apr; 86():115-123. PubMed ID: 30576704
[TBL] [Abstract][Full Text] [Related]
20. Molecular Melanoma Diagnosis Update: Gene Fusion, Genomic Hybridization, and Massively Parallel Short-Read Sequencing.
Lang UE; Yeh I; McCalmont TH
Clin Lab Med; 2017 Sep; 37(3):473-484. PubMed ID: 28802496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]